Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Mechanistic Study to Evaluate Impact of Subcutaneous Implants of Afamelanotide on Ultraviolet Radiation-induced DNA Damage and DNA Repair Capacity in Healthy Volunteers With Skin Types I-III

NCT05368857 is registered in ClinicalTrials.gov with Clinuvel (UK) Ltd. as lead sponsor.

NCT NCT05368857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05368857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Mechanistic Study to Evaluate Impact of Subcutaneous Implants of Afamelanotide on Ultraviolet Radiation-induced DNA Damage and DNA Repair Capacity in Healthy Volunteers With Skin Types I-III
Lead sponsor
Clinuvel (UK) Ltd.
Phase
Phase 1
Overall status
Completed
Start date
January 19, 2022
Completion date
February 1, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

afamelanotide evaluated as skin dna repair therapy in healthy volunteers